Interferon-γ receptor 1 promoter polymorphisms:: population distribution and functional implications

被引:33
|
作者
Rosenzweig, SD
Schäffer, AA
Ding, L
Sullivan, R
Enyedi, B
Yim, JJ
Cook, JL
Musser, JM
Holland, SM
机构
[1] NIAID, Immunopathogenesis Sect, Host Def Lab, NIH,DHHS, Bethesda, MD 20892 USA
[2] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, DHHS, Bethesda, MD 20892 USA
[3] Univ Illinois, Infect Dis Sect, Dept Med, Chicago, IL 60607 USA
[4] NIAID, Lab Human Bcterial Pathogenesis, NIH, DHHS, Hamilton, MT 59840 USA
关键词
single nucleotide polymorphisms; mycobacteria; pulmonary; disseminated; haplotype; avium;
D O I
10.1016/j.clim.2004.03.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Different polymorphisms have been described in the minimal promoter region (MPR) of the interferon-gamma receptor 1 (IFNGR1), a molecule that plays a critical role in mycobacterial control. We sequenced the IFNGR1 MPR from African American, Caucasian and Korean controls, and from mycobacteria-infected patients. Six different single nucleotide polymorphisms (SNPs) were detected in the IFNGR1 MPR. The three ethnic groups showed different SNP distribution patterns, but no significant differences were detected between mycobacterial cases and controls. Two polymorphisms were found in all populations (G-611A, T-56C). We cloned the four allelic variants (var) of haplotype G-611A/T-56C into a luciferase reporter vector and determined their promoter activity. Polymorphisms at position -611 had a stronger effect on the promoter activity than those at position -56, and constructs carrying G-611 produced a stronger promoter activity than -611A constructs. The IFNGR1 MPR is a polymorphic region with at least two SNPs influencing its activity, but these are not associated with increased mycobacterial susceptibility. Published by Elsevier Inc.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 50 条
  • [21] Functional significance of globotriaosyl ceramide in interferon-α2/type 1 interferon receptor-mediated antiviral activity
    Khine, AA
    Lingwood, CA
    JOURNAL OF CELLULAR PHYSIOLOGY, 2000, 182 (01) : 97 - 108
  • [22] A regulatory polymorphism in interferon-γ receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection
    Zhou, Jie
    Chen, Ding-Qiang
    Poon, Vincent K. M.
    Zeng, Yong
    Ng, Fai
    Lu, Liwei
    Huang, Jian-Dong
    Yuen, Kwok-Yung
    Zheng, Bo-Jian
    IMMUNOGENETICS, 2009, 61 (06) : 423 - 430
  • [23] A regulatory polymorphism in interferon-γ receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection
    Jie Zhou
    Ding-Qiang Chen
    Vincent K. M. Poon
    Yong Zeng
    Fai Ng
    Liwei Lu
    Jian-Dong Huang
    Kwok-Yung Yuen
    Bo-Jian Zheng
    Immunogenetics, 2009, 61 : 423 - 430
  • [24] Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population
    Yonghe You
    Jieqiong Deng
    Jian Zheng
    Lan Jiang
    Na Li
    Hongchun Wu
    Wei Li
    Jiachun Lu
    Yifeng Zhou
    Bin Ni
    Molecular Biology Reports, 2013, 40 : 829 - 838
  • [25] Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population
    You, Yonghe
    Deng, Jieqiong
    Zheng, Jian
    Jiang, Lan
    Li, Na
    Wu, Hongchun
    Li, Wei
    Lu, Jiachun
    Zhou, Yifeng
    Ni, Bin
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (02) : 829 - 838
  • [26] Functional significance of the Toll-like receptor 4 promoter gene polymorphisms in the Chinese Han population
    Chen, Kehong
    Wang, Yong-tang
    Gu, Wei
    Zeng, Ling
    Jiang, Dong-po
    Du, Ding-yuan
    Hu, Ping
    Duan, Zhao-xia
    Liu, Qing
    Huang, S. N.
    Jiang, Jian-xin
    CRITICAL CARE MEDICINE, 2010, 38 (05) : 1292 - 1299
  • [27] Polymorphisms of type I interferon receptor 1 promoter and their effects on chronic hepatitis B virus infection
    Zhou, Jie
    Lu, Liwei
    Yuen, Man-Fung
    Lam, Ting-Wa
    Chung, Chi-Ping
    Lam, Chun-Lit
    Zhang, Bin
    Wang, Song
    Chen, Yu
    Wu, Sharon H. W.
    Poon, Vincent K. M.
    Ng, Fai
    Chan, Chris C. S.
    Jiang, Shibo
    Yuen, Kwok-Yung
    Zheng, Bo-Jian
    JOURNAL OF HEPATOLOGY, 2007, 46 (02) : 198 - 205
  • [28] Contribution of Irf-1 promoter polymorphisms to the Th1-type cell response and interferon-β monotherapy for chronic hepatitis C
    Saito, H
    Tada, S
    Nakamoto, N
    Kitamura, K
    Horikawa, H
    Kurita, S
    Ebinuma, H
    Ishii, H
    Takahashi, M
    Tanaka, S
    Hibi, T
    HEPATOLOGY RESEARCH, 2005, 32 (01) : 25 - 32
  • [29] Disseminated histoplasmosis in persons with interferon-γ receptor 1 deficiency
    Zerbe, CS
    Holland, SM
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (04) : E38 - E41
  • [30] Structure-function analysis of interferon-β promoter stimulator-1
    Johnson, Cynthia L.
    Hagan, Kristan A.
    Erickson, Andrea K.
    Saito, Takeshi
    Gale, Michael, Jr.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (08): : 721 - 722